P059 Wellbeing and shielding of patients with rheumatic disease on biologic therapy during the early COVID-19 pandemic: a single centre experience
Conclusion This study gives initial insights into the behaviours and concerns of patients with autoimmune and inflammatory disease on biologic therapy during the first wave of COVID-19 in the UK. Wellbeing and disease management have considerably suffered for many individuals. Further understanding patient experience may help guide restructuring of rheumatology services in next phase of the UK pandemic.Disclosure L.M. Carter: None.H. Irvine: None.A. D ’Cunha Kamath: None.A. Sahni: None.P. Hanna: None.N. Rahimi: None.K. Bhamra: None.
Source: Rheumatology - Category: Rheumatology Source Type: research
More News: Anxiety | Autoimmune Disease | COVID-19 | Databases & Libraries | Men | Pandemics | Primary Care | Rheumatology | Sports Medicine | Study | UK Health